Clinical characteristics and mortality risk among critically ill patients with COVID-19 owing to the B.1.617.2 (Delta) variant in Vietnam : A retrospective observational study
Copyright: © 2023 Do et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited..
BACKGROUND: SARS-CoV-2 Delta variant caused a large number of COVID-19 cases in many countries, including Vietnam. Understanding mortality risk factors is crucial for the clinical management of severe COVID-19.
METHODS: We conducted a retrospective study at an intensive care center in Ho Chi Minh City that urgently built by Bach Mai Hospital during the COVID-19 outbreak in Vietnam, when the Delta variant predominated. Participants were laboratory-confirmed patients with SARS-CoV-2 infection, admitted in August 2021. Data on patients' demographic and clinical characteristics, radiographic and laboratory findings, treatment, and clinical time course were compared between survivors and non-survivors. Risk factors to mortality were assessed using logistic regression.
RESULTS: Among 504 eligible COVID-19 patients, case fatality was 52.2%. Unvaccinated patients accounted for 61.2% of non-survivors and 43.6% of survivors (p < 0.001). The time from onset to hospital admission was 8 days in non-survivors and 7 days in survivors (p = 0.004). Among non-survivors, 90.2% developed acute respiratory distress syndrome (ARDS). Oxygen therapy was administered for all patients, but antiviral agent was given to 51.7% of non-survivors. 54.2% of non-survivors tested positive for the bacterial infection using blood culture. The risk factors for mortality were diabetes mellitus, respiration rate, oxygen saturation, vaccination status, time from onset to admission, and older age.
CONCLUSIONS: Critical patients with COVID-19 owing to the Delta variant in Vietnam had delayed hospital admission, leading to ARDS and death. Early availability of vaccines and preventing bacterial infections are crucial for reducing mortality of COVID-19, especially in low- and middle-income countries.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
PloS one - 18(2023), 1 vom: 10., Seite e0279713 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Do, Thanh Van [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Completed 24.01.2023 Date Revised 18.11.2023 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.1371/journal.pone.0279713 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM351734538 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM351734538 | ||
| 003 | DE-627 | ||
| 005 | 20231226052108.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1371/journal.pone.0279713 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1172.xml |
| 035 | |a (DE-627)NLM351734538 | ||
| 035 | |a (NLM)36662716 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Do, Thanh Van |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical characteristics and mortality risk among critically ill patients with COVID-19 owing to the B.1.617.2 (Delta) variant in Vietnam |b A retrospective observational study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.01.2023 | ||
| 500 | |a Date Revised 18.11.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright: © 2023 Do et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | ||
| 520 | |a BACKGROUND: SARS-CoV-2 Delta variant caused a large number of COVID-19 cases in many countries, including Vietnam. Understanding mortality risk factors is crucial for the clinical management of severe COVID-19 | ||
| 520 | |a METHODS: We conducted a retrospective study at an intensive care center in Ho Chi Minh City that urgently built by Bach Mai Hospital during the COVID-19 outbreak in Vietnam, when the Delta variant predominated. Participants were laboratory-confirmed patients with SARS-CoV-2 infection, admitted in August 2021. Data on patients' demographic and clinical characteristics, radiographic and laboratory findings, treatment, and clinical time course were compared between survivors and non-survivors. Risk factors to mortality were assessed using logistic regression | ||
| 520 | |a RESULTS: Among 504 eligible COVID-19 patients, case fatality was 52.2%. Unvaccinated patients accounted for 61.2% of non-survivors and 43.6% of survivors (p < 0.001). The time from onset to hospital admission was 8 days in non-survivors and 7 days in survivors (p = 0.004). Among non-survivors, 90.2% developed acute respiratory distress syndrome (ARDS). Oxygen therapy was administered for all patients, but antiviral agent was given to 51.7% of non-survivors. 54.2% of non-survivors tested positive for the bacterial infection using blood culture. The risk factors for mortality were diabetes mellitus, respiration rate, oxygen saturation, vaccination status, time from onset to admission, and older age | ||
| 520 | |a CONCLUSIONS: Critical patients with COVID-19 owing to the Delta variant in Vietnam had delayed hospital admission, leading to ARDS and death. Early availability of vaccines and preventing bacterial infections are crucial for reducing mortality of COVID-19, especially in low- and middle-income countries | ||
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 700 | 1 | |a Manabe, Toshie |e verfasserin |4 aut | |
| 700 | 1 | |a Vu, Giap Van |e verfasserin |4 aut | |
| 700 | 1 | |a Nong, Vuong Minh |e verfasserin |4 aut | |
| 700 | 1 | |a Fujikura, Yuji |e verfasserin |4 aut | |
| 700 | 1 | |a Phan, Dung |e verfasserin |4 aut | |
| 700 | 1 | |a Pham, Thach The |e verfasserin |4 aut | |
| 700 | 1 | |a Do, Cuong Duy |e verfasserin |4 aut | |
| 700 | 1 | |a Doan, Tra Thu |e verfasserin |4 aut | |
| 700 | 1 | |a Nguyen, Nguyen Trung |e verfasserin |4 aut | |
| 700 | 1 | |a Nguyen, Thai Quoc |e verfasserin |4 aut | |
| 700 | 1 | |a Dong, Thanh Van |e verfasserin |4 aut | |
| 700 | 1 | |a Luong, Chinh Quoc |e verfasserin |4 aut | |
| 700 | 1 | |a Manabe, Hiroki |e verfasserin |4 aut | |
| 700 | 1 | |a Kambayashi, Dan |e verfasserin |4 aut | |
| 700 | 1 | |a Hoang, Anh Viet |e verfasserin |4 aut | |
| 700 | 1 | |a Vu, Nhan Van |e verfasserin |4 aut | |
| 700 | 1 | |a Trinh, Giang Kim |e verfasserin |4 aut | |
| 700 | 1 | |a Do, Son Ngoc |e verfasserin |4 aut | |
| 700 | 1 | |a Kamiya, Takeshi |e verfasserin |4 aut | |
| 700 | 1 | |a Ohara, Hirotaka |e verfasserin |4 aut | |
| 700 | 1 | |a Nguyen, Chi Van |e verfasserin |4 aut | |
| 700 | 1 | |a Dang, Tuan Quoc |e verfasserin |4 aut | |
| 700 | 1 | |a Kudo, Koichiro |e verfasserin |4 aut | |
| 700 | 1 | |a Dao, Co Xuan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t PloS one |d 2006 |g 18(2023), 1 vom: 10., Seite e0279713 |w (DE-627)NLM167327399 |x 1932-6203 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2023 |g number:1 |g day:10 |g pages:e0279713 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1371/journal.pone.0279713 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2023 |e 1 |b 10 |h e0279713 | ||